HAL-PDT for Cervical Intraepithelial Neoplasia Grade 2 | MicrobiomeTrials← Back to trialsNCT07634497
HAL-PDT for Cervical Intraepithelial Neoplasia Grade 2
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2028-06-15
Enrollment target: 500 participants Other microbiome trials you might be interested in
Papillomavirus Infections
This study will evaluate the efficacy, immunogenicity and safety of 9-valent human papillomavirus (9vHPV; V503) vaccine …
Guilin, ChinaEst. completion Mar 31, 2028
HIV InfectionsHPV InfectionCervix CancerCIN2CIN3CIN1CINCervical Intraepithelial Neoplasia Grade 3Cervical Intraepithelial Neoplasia Grade 1
Cervical Intraepithelial Neoplasia Grade 2/3
This randomized, placebo-controlled trial will evaluate self-administered 5-fluorouracil (5FU) to improve human papillom…
Kisumu, KenyaEst. completion Sep 2027